NUFARM BOND ADJUVANT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm bond adjuvant

nufarm australia limited - synthetic latex; alcohol ethoxylate - liquid - synthetic latex ungrouped active 450.0 g/l; alcohol ethoxylate emulsifiers & surfactants active 100.0 g/l - adjuvant - agricultural chemical additive | spray activator | spreading agent | wetting agent - extender/sticker/spreader | tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

LOVELAND PRODUCTS BOND ADJUVANT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

loveland products bond adjuvant

loveland products inc - synthetic latex; alcohol ethoxylate - liquid - synthetic latex ungrouped active 450.0 g/l; alcohol ethoxylate emulsifiers & surfactants active 100.0 g/l - adjuvant - agricultural chemical additive | spray activator | spreading agent | wetting agent - extender/sticker/spreader | tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

BIND-R ADJUVANT Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bind-r adjuvant

dksh agrisolutions pty ltd - synthetic latex; alcohol ethoxylate - liquid - synthetic latex ungrouped active 450.0 g/l; alcohol ethoxylate emulsifiers & surfactants active 100.0 g/l - adjuvant - agricultural chemical additive | spray activator | spreading agent | wetting agent - additive - refer to label | extender/sticker/spreader

DESIGNER ENHANCED WETTER AND STICKER Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

designer enhanced wetter and sticker

loveland products inc - synthetic latex; organosilicone surfactant fluid - liquid - synthetic latex ungrouped active 255.0 g/l; organosilicone surfactant fluid emulsifiers & surfactants active 385.0 g/l - adjuvant - foliar nutrients additive | fungicide additive | growth regulator additive | insecticide additive | low volume application | add - carrier - anti-evaporant | spreading agent | vegetable - refer to label | vines - refer to label | wetting agent (use as directed) | adjuvant | evaporant | herbicide application | improve penetrating properties | insecticide application | wetter

Synthetic-polymer liquid barrier dressing, non-sterile Australia - English - Department of Health (Therapeutic Goods Administration)

synthetic-polymer liquid barrier dressing, non-sterile

pharmacare laboratories pty ltd - 58978 - synthetic-polymer liquid barrier dressing, non-sterile - synthetic-polymer liquid barrier dressing, non-sterile: a liquid spray-on preparation composed of synthetic polymer materials intended to form a thin protective film when applied to superficial wounds (e.g., minor cuts, abrasions) to reduce exposure to external contaminants.

Synthetic bone 4Bone SBS & MBCP  - Bone matrix implant, artificial Australia - English - Department of Health (Therapeutic Goods Administration)

synthetic bone 4bone sbs & mbcp - bone matrix implant, artificial

more group pty ltd - 17751 - bone matrix implant, synthetic - synthetic bone replacement of bone for surgery and implantology surgical bone grafting,the product is a mixture of ha/tcp (60:40 or 20:80). the synthetic bone substitutes are available in various shapes and sizes in order to fill various bone defects

DISTRIBUTION WETTER 1000 Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

distribution wetter 1000

grow choice pty ltd - alcohol alkoxylate - liquid - alcohol alkoxylate emulsifiers & surfactants active 1000.0 g/l - wetting agent - herbicide additive | knapsack application | water tanker | activator | penetrant | post emergent herbicide | spreading adjuvant - spreading agent | wetting agent (use as directed) | improve penetrating properties

WSD WETTER 1000 Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd wetter 1000

wsd agribusiness pty ltd - alcohol alkoxylate - liquid - alcohol alkoxylate emulsifiers & surfactants active 1000.0 g/l - wetting agent - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - carrier - anti-evaporant | spreading agent | adjuvant | evaporant | herbicide application | insecticide application | wetter

FERTAGYL SYNTHETIC GONADOTROPHIN RELEASING HORMONE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fertagyl synthetic gonadotrophin releasing hormone

intervet australia pty limited - gonadorelin as gonadorelin acetate; benzyl alcohol - parenteral liquid/solution/suspension - gonadorelin as gonadorelin acetate hormone-gonadotrophin active 0.1 mg/ml; benzyl alcohol benzene other 10.0 mg/ml - endocrine system - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - trophic hormones | cystic ovaries

CENESTIN- synthetic conjugated estrogens, a tablet, film coated United States - English - NLM (National Library of Medicine)

cenestin- synthetic conjugated estrogens, a tablet, film coated

physicians total care, inc. - estrogens, conjugated synthetic a (unii: jm2621p2ls) (estrogens, conjugated synthetic a - unii:jm2621p2ls) - estrogens, conjugated synthetic a 0.45 mg - cenestin therapy is indicated for the: 1. treatment of moderate-to-severe vasomotor symptoms associated with the menopause. - 0.45 mg cenestin - 0.625 mg cenestin - 0.9 mg cenestin - 1.25 mg cenestin 2. treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - 0.3 mg cenestin cenestin should not be used in women with any of the following conditions: - undiagnosed abnormal genital bleeding. - known, suspected, or history of cancer of the breast. - known or suspected estrogen-dependent neoplasia. - active deep vein thrombosis, pulmonary embolism or a history of these conditions. - active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction). - liver dysfunction or disease. - cenestin therapy should not be used in patients with known hypersensitivity to its ingredients. - known or su